Literature DB >> 12372592

How the lipid-free structure of the N-terminal truncated human apoA-I converts to the lipid-bound form: new insights from NMR and X-ray structural comparison.

Guangshun Wang1.   

Abstract

The X-ray structure of the N-terminal truncated human apoA-I [Borhani et al., Proc. Natl. Acad. Sci. USA 94 (1997) 12291] and the NMR structure of intact human apoA-I [Okon et al., FEBS Lett. 517 (2002) 139] found similar repeating helices. The crystal structure is a twisted circular four-helix bundle, consisting of four molecules of apoA-I(44-243), where four copies of the lecithin:cholesterol acyltransferase (LCAT)-activating domains are located outside the ring structure, while the aromatic-rich strong lipid-binding domains are inside. This architecture suggests a lipid-binding mechanism that lipids directly enter the hole of the crystal structure. Indeed, four copies of Trp50 and Trp72 are exposed and oriented toward the center of the ring, initiating lipid binding. This is followed by the inside-out rotations of the terminal helices to make a belt with all the hydrophobic faces of the helices facing inward. Such lipid-binding induced rotations have an impact on the conformation of the lipid-free form. Indeed, the structure of residues 78-81 changes from helical (free) to disordered (bound) while the structure of residues 221-227 changes from extended to helical.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372592     DOI: 10.1016/s0014-5793(02)03354-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  APD: the Antimicrobial Peptide Database.

Authors:  Zhe Wang; Guangshun Wang
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Solution structure of the N-terminal amphitropic domain of Escherichia coli glucose-specific enzyme IIA in membrane-mimetic micelles.

Authors:  Guangshun Wang; Paul A Keifer; Alan Peterkofsky
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.

Authors:  Geoffrey D Wool; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-03-05       Impact factor: 5.922

4.  Prediction of antimicrobial peptides based on sequence alignment and feature selection methods.

Authors:  Ping Wang; Lele Hu; Guiyou Liu; Nan Jiang; Xiaoyun Chen; Jianyong Xu; Wen Zheng; Li Li; Ming Tan; Zugen Chen; Hui Song; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

5.  Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.

Authors:  Winde Jorissen; Elien Wouters; Jeroen F Bogie; Tim Vanmierlo; Jean-Paul Noben; Denis Sviridov; Niels Hellings; Veerle Somers; Roland Valcke; Bart Vanwijmeersch; Piet Stinissen; Monique T Mulder; Alan T Remaley; Jerome J A Hendriks
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

Review 6.  The physiology of foamy phagocytes in multiple sclerosis.

Authors:  Elien Grajchen; Jerome J A Hendriks; Jeroen F J Bogie
Journal:  Acta Neuropathol Commun       Date:  2018-11-19       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.